The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

VRCA FINANCIAL STATEMENTS

Verrica Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

VRCAVerrica Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-50 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue30.3 M $Gross Profit26 M $ · 86%Operating Income-28.1 M $ · -93%Pre-tax Income-31.2 M $ · -103%Net Income to Owners-31.2 M $ · -103%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue30.3 M $+106.2%
Gross Profit26 M $+104.6%
Operating Income-28.1 M $—
EBITDA-26.5 M $—
Net Income to Owners-31.2 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
050 M100 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets36 M
  • Equity4.3 M $12%
  • Current Liabilities22.4 M $62%
  • Long-term Liabilities9.3 M $26%

Key Figures

YoY change
Total Assets36 M $-7.9%
Total Liabilities31.7 M $-44.0%
Total Equity4.3 M $—
Cash & ST Investments11.2 M $-27.3%
Total Debt1.8 M $-95.3%
Net Debt-9.4 M $-140.0%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-60 M-40 M-20 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-20 M-10 M0-22.5 M $Operating9.3 M $Financing-13.2 M $Net Change

Key Figures

YoY change
Operating Cash Flow-22.5 M $—
Capital Expenditures0 $-100.0%
Free Cash Flow-22.5 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on VRCA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.